Conference Coverage

Beware nonopiate meds with high street value


 

EXPERT ANALYSIS FROM ACP INTERNAL MEDICINE


“It’s tricky, because you can potentially spare having to use high-dose opioids by adding gabapentin,” Dr. Walley observed. “So, as prescribers, you’re in a difficult position, because there’s a mixed message here: When gabapentin is combined with opioids, that’s when it’s dangerous – but that’s also when they’re potentially more effective for pain.”

Promethazine

This drug has a host of neurobiologic actions, which collectively provide sedative and antiemetic effects. Promethazine jacks up opioid-induced euphoria and alleviates withdrawal symptoms. It’s commonly detected in toxicology testing of patients on prescription opioids for chronic pain or on methadone therapy for opioid use disorder.

National Poison Data System figures show an unwelcome trend: A sharp uptick in promethazine abuse/misuse beginning in 2008, even while the total number of poisoning events of all kinds reported to the system began a steady decline (J Addict Med. 2015 May-Jun;9[3]:233-7).

Clonidine

This centrally acting alpha2-adrenoreceptor and imidazoline-receptor agonist is indicated for treatment of hypertension. However, it’s also extensively used off-label to treat anxiety, as well as for alcohol and opioid withdrawal symptoms. The problem is, clonidine boosts opioid-induced euphoria.

Pages

Recommended Reading

MDedge Daily News: Does more marijuana mean fewer opioids?
MDedge Rheumatology
CMS finalizes measures to help combat opioid crisis
MDedge Rheumatology
Life and health are not even across the U.S.
MDedge Rheumatology
Medical marijuana’s ‘Catch-22’: Federal limits on research hinder patients’ relief
MDedge Rheumatology
Mixed outcomes in analysis of NSAIDs and IBD exacerbation
MDedge Rheumatology
MDedge Daily News: Shingles boosts stroke risk
MDedge Rheumatology
MDedge Daily News: Can a nasal spray reverse suicidality?
MDedge Rheumatology
MDedge Daily News: Physician burnout needs more than yoga
MDedge Rheumatology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Rheumatology
FDA advisory committee votes to recommend update to celecoxib safety labeling
MDedge Rheumatology